What is the share price of Remus Pharmaceuticals Ltd (REMUS) today?
The share price of REMUS as on 5th December 2025 is ₹650.65. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Remus Pharmaceuticals Ltd (REMUS) share?
The past returns of Remus Pharmaceuticals Ltd (REMUS) share are- Past 1 week: -0.64%
- Past 1 month: -16.34%
- Past 3 months: -22.62%
- Past 6 months: -34.62%
- Past 1 year: -49.30%
- Past 3 years: N/A%
- Past 5 years: 189.69%
What are the peers or stocks similar to Remus Pharmaceuticals Ltd (REMUS)?
The peers or stocks similar to Remus Pharmaceuticals Ltd (REMUS) include:What is the dividend yield % of Remus Pharmaceuticals Ltd (REMUS) share?
The current dividend yield of Remus Pharmaceuticals Ltd (REMUS) is 0.12.What is the market cap of Remus Pharmaceuticals Ltd (REMUS) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Remus Pharmaceuticals Ltd (REMUS) is ₹766.73 Cr as of 5th December 2025.What is the 52 week high and low of Remus Pharmaceuticals Ltd (REMUS) share?
The 52-week high of Remus Pharmaceuticals Ltd (REMUS) is ₹1314.50 and the 52-week low is ₹630.What is the PE and PB ratio of Remus Pharmaceuticals Ltd (REMUS) stock?
The P/E (price-to-earnings) ratio of Remus Pharmaceuticals Ltd (REMUS) is 26.38. The P/B (price-to-book) ratio is 2.71.Which sector does Remus Pharmaceuticals Ltd (REMUS) belong to?
Remus Pharmaceuticals Ltd (REMUS) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Remus Pharmaceuticals Ltd (REMUS) shares?
You can directly buy Remus Pharmaceuticals Ltd (REMUS) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Remus Pharmaceuticals Ltd
REMUS Share Price
650.652.91% (-19.50)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
REMUS Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
REMUS Performance & Key Metrics
REMUS Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| — | 2.71 | 0.12% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.87 | 5.82 | 0.59% |
REMUS Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
REMUS Company Profile
Remus Pharmaceuticals Ltd markets and distributes pharmaceutical formulations and active pharmaceutical ingredients, specializing in various therapeutic areas including oncology and cardiovascular health.
SUNPHARMA
PE Ratio
39.63
39.63
1Y Return
0.45%
0.45%
Buy Reco %
91.67
91.67
TORNTPHARM
PE Ratio
67.04
67.04
1Y Return
12.63%
12.63%
Buy Reco %
76.92
76.92
CIPLA
PE Ratio
23.30
23.30
1Y Return
1.51%
1.51%
Buy Reco %
70.00
70.00
DRREDDY
PE Ratio
18.77
18.77
1Y Return
2.85%
2.85%
Buy Reco %
41.94
41.94
LUPIN
PE Ratio
29.21
29.21
1Y Return
1.24%
1.24%
Buy Reco %
72.22
72.22
REMUS Forecast
REMUS Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
REMUS
REMUS
Income
Balance Sheet
Cash Flow
Annual Normal View
REMUS Income Statement
REMUS Income Statement
Annual Normal View
| Financial Year | FY 2024 | FY 2025 | TTM | |||
|---|---|---|---|---|---|---|
| Total Revenue | 215.77 | 625.34 | — | |||
Raw Materials | 164.14 | 541.31 | — | |||
| Power & Fuel Cost | 0.01 | 0.06 | ||||
| Employee Cost | 7.32 | 13.11 | ||||
| Selling & Administrative Expenses | 8.36 | 19.19 | ||||
| Operating & Other expenses | 4.15 | 1.00 | ||||
EBITDA | 31.79 | 50.67 | — | |||
| Depreciation/Amortization | 1.12 | 1.87 | — | |||
| PBIT | 30.67 | 48.80 | — | |||
| Interest & Other Items | 0.50 | 1.46 | — | |||
| PBT | 30.17 | 47.34 | — | |||
| Taxes & Other Items | 9.65 | 18.27 | — | |||
| Net Income | 20.52 | 29.07 | — | |||
| EPS | 17.41 | 24.67 | — | |||
| DPS | 0.75 | 0.75 | — | |||
| Payout ratio | 0.04 | 0.03 | — |
REMUS Company Updates
REMUS Stock Peers
REMUS Past Performance & Peer Comparison
REMUS Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Remus Pharmaceuticals Ltd | 26.38 | 2.71 | 0.12% |
| Sun Pharmaceutical Industries Ltd | 39.63 | 5.98 | 0.89% |
| Torrent Pharmaceuticals Ltd | 67.04 | 16.88 | 0.85% |
| Cipla Ltd | 23.30 | 3.93 | 1.05% |
REMUS Stock Price Comparison
Compare REMUS with any stock or ETFCompare REMUS with any stock or ETF
REMUS
REMUS Holdings
REMUS Shareholdings
REMUS Promoter Holdings Trend
REMUS Promoter Holdings Trend
REMUS Institutional Holdings Trend
REMUS Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
REMUS Shareholding Pattern
REMUS Shareholding Pattern
REMUS Shareholding History
REMUS Shareholding History
Foreign Institutions
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing REMUS stock
smallcases containing REMUS stock
Looks like this stock is not in any smallcase yet.
REMUS Events
REMUS Events
REMUS Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
REMUS Dividend Trend
No dividend trend available
REMUS Upcoming Dividends
REMUS Upcoming Dividends
No upcoming dividends are available
REMUS Past Dividends
REMUS Past Dividends
Cash Dividend
Ex DateEx DateNov 14, 2025
Interim 1
Interim 1 | Div/Share: ₹0.50
Dividend/Share
₹0.50
Ex DateEx Date
Nov 14, 2025
Cash Dividend
Ex DateEx DateSep 18, 2025
Final
Final | Div/Share: ₹0.50
Dividend/Share
₹0.50
Ex DateEx Date
Sep 18, 2025
Cash Dividend
Ex DateEx DateNov 19, 2024
Interim
Interim | Div/Share: ₹1.00
Dividend/Share
₹1.00
Ex DateEx Date
Nov 19, 2024
Cash Dividend
Ex DateEx DateMay 2, 2024
Interim 2
Interim 2 | Div/Share: ₹4.00
Dividend/Share
₹4.00
Ex DateEx Date
May 2, 2024
Cash Dividend
Ex DateEx DateOct 27, 2023
Interim
Interim | Div/Share: ₹2.00
Dividend/Share
₹2.00
Ex DateEx Date
Oct 27, 2023
REMUS Stock News & Opinions
REMUS Stock News & Opinions
Articles & Videos
Corporate
Board of Remus Pharmaceuticals recommends First Interim Dividend
Remus Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 10 November 2025, has recommended a First Interim Dividend of Rs.0.50 per share (i.e.0.05), subject to the approval of the shareholders.Powered by Capital Market - Live
3 weeks agoCapital Market - Live
Corporate
Remus Pharmaceuticals to table results
Remus Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 10 November 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Remus Pharmaceuticals to convene AGM
Remus Pharmaceuticals announced that the 10th Annual General Meeting(AGM) of the company will be held on 25 September 2025.Powered by Capital Market - Live
2 months agoCapital Market - Live
Corporate
Remus Pharmaceuticals schedules AGM
Remus Pharmaceuticals announced that the 15th Annual General Meeting(AGM) of the company will be held on 24 September 2025.Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Remus Pharmaceuticals announces board meeting date
Remus Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 25 September 2025.Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Board of Remus Pharmaceuticals recommends final dividend
Remus Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 17 May 2025, inter alia, have recommended the final dividend of Rs 0.5 per equity Share (i.e. 5%) , subject to the approval of the shareholders.Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Remus Pharmaceuticals to table results
Remus Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 17 May 2025.Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Board of Remus Pharmaceuticals recommends interim dividend
Remus Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 9 November 2024, inter alia, have recommended the interim dividend of Rs 1 per equity Share (i.e. 10%) , subject to the approval of the shareholders.Powered by Capital Market - Live
1 year agoCapital Market - Live
Corporate
Remus Pharmaceuticals to convene board meeting
Remus Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 9 November 2024Powered by Capital Market - Live
1 year agoCapital Market - Live
Corporate
Remus Pharmaceuticals to convene AGM
Remus Pharmaceuticals announced that the 9th Annual General Meeting (AGM) of the company will be held on 20 September 2024.Powered by Capital Market - Live
1 year agoCapital Market - Live
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant